Cargando…
Effect of immune checkpoint inhibitors in patients with gastric hepatoid adenocarcinoma: a case report and literature review
Gastric hepatoid adenocarcinoma (GHAC) is a highly aggressive histological subtype of gastric cancer (GC) with similar tissue morphology to hepatocellular carcinoma. GHAC frequently produces alpha-fetoprotein (AFP) and has a poor prognosis; however, standardized treatment remains elusive. We report...
Autores principales: | Sun, Yansha, Chang, Wanhua, Yao, Juan, Liu, Haiyan, Zhang, Xiaofei, Wang, Wei, Zhao, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087251/ https://www.ncbi.nlm.nih.gov/pubmed/35469480 http://dx.doi.org/10.1177/03000605221091095 |
Ejemplares similares
-
Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma
por: Li, Wei, et al.
Publicado: (2020) -
Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature
por: Yang, Kun, et al.
Publicado: (2019) -
Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature
por: Yoshizawa, Junichi, et al.
Publicado: (2017) -
Therapeutic Approaches to Gastric Hepatoid Adenocarcinoma: Current Perspectives
por: Søreide, Jon Arne
Publicado: (2019) -
Hepatoid adenocarcinoma of the gallbladder
por: Ellouze , Sameh, et al.
Publicado: (2011)